Coreopsis tinctoria buds polysaccharides boost metformin's antihyperglycemic effect in diabetic mice via gut microbiota and metabolism modulation

Coreopsis tinctoria bud is a characteristic plant of Xinjiang Uygur Autonomous Region, and it has various biological activities.This study investigated the effects of low-dose metformin (LMET) and the sodium hydroxide extract of Coreopsis tinctoria buds polysaccharides (Al) on streptozotocin-induced diabetes. The aim was to explore the potential mechanisms of LMET+Al and metformin alone in treating diabetes. The results showed that both metformin and LMET+Al could reduce weight loss and improve hyperglycemia in mice. Specifically, LMET+Al effectively lowered fasting blood glucose, enhanced glucose tolerance, promoted glycogen synthesis, improved islet function, and stimulated insulin secretion. It also better prevented islet cell atrophy by inhibiting cleaved Caspase-3 and the inflammatory factor NLRP-3. Gut microbiota analysis revealed higher levels of the probiotic Ligilactobacillus in the LMET+Al group compared to the metformin group. Metabolite analysis indicated that LMET+Al regulated diabetic mice through pathways like Aspartate Metabolism and Sphingolipid Metabolism. Correlation analysis showed that gut microbiota and metabolites were closely linked, with sphingosine positively correlated with Muribaculum and Alistipes_A ( p < 0.05) and negatively correlated with Acinetobacter ( p < 0.05). These interactions collectively contributed to host health. The findings suggest that Al may serve as a useful adjunct hypoglycemic agent for metformin in future applications. • The hypoglycemic effect of the combined application of Lose-dose Al and metformin is better than that of metformin alone. • Lose-dose Al and metformin protectd pancreatic tissue by reducing damage and suppressing cleaved Caspase-3/NLRP-3 expression. • Lose-dose Al and metformin modulatedgut microbiota, notably increasing beneficial Ligilactobacillus abundance. • Lose-dose Al and metformin improved metabolic disorders and demonstrates potential as a natural anti-diabetic agent.

Authors

Institutions

Publication Details

Journal
Industrial Crops and Products
Published
2026-01-13
DOI
https://doi.org/10.1016/j.indcrop.2025.122574
Primary Topic
Metabolism, Diabetes, and Cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Coreopsis tinctoria buds polysaccharides boost metformin's antihyperglycemic effect in diabetic mice via gut microbiota and metabolism modulation

Yijiao Sun, Yang Wang, Jun Ruan, Deyan Zhu et al.
Industrial Crops and Products
Metabolism, Diabetes, and Cancer
article

Coreopsis tinctoria buds polysaccharides boost metformin's antihyperglycemic effect in diabetic mice via gut microbiota and metabolism modulation

Yijiao Sun, Yang Wang, Jun Ruan, Deyan Zhu, Yufeng Li, Rong Li
article en

Abstract

Coreopsis tinctoria bud is a characteristic plant of Xinjiang Uygur Autonomous Region, and it has various biological activities.This study investigated the effects of low-dose metformin (LMET) and the sodium hydroxide extract of Coreopsis tinctoria buds polysaccharides (Al) on streptozotocin-induced diabetes. The aim was to explore the potential mechanisms of LMET+Al and metformin alone in treating diabetes. The results showed that both metformin and LMET+Al could reduce weight loss and improve hyperglycemia in mice. Specifically, LMET+Al effectively lowered fasting blood glucose, enhanced glucose tolerance, promoted glycogen synthesis, improved islet function, and stimulated insulin secretion. It also better prevented islet cell atrophy by inhibiting cleaved Caspase-3 and the inflammatory factor NLRP-3. Gut microbiota analysis revealed higher levels of the probiotic Ligilactobacillus in the LMET+Al group compared to the metformin group. Metabolite analysis indicated that LMET+Al regulated diabetic mice through pathways like Aspartate Metabolism and Sphingolipid Metabolism. Correlation analysis showed that gut microbiota and metabolites were closely linked, with sphingosine positively correlated with Muribaculum and Alistipes_A ( p < 0.05) and negatively correlated with Acinetobacter ( p < 0.05). These interactions collectively contributed to host health. The findings suggest that Al may serve as a useful adjunct hypoglycemic agent for metformin in future applications. • The hypoglycemic effect of the combined application of Lose-dose Al and metformin is better than that of metformin alone. • Lose-dose Al and metformin protectd pancreatic tissue by reducing damage and suppressing cleaved Caspase-3/NLRP-3 expression. • Lose-dose Al and metformin modulatedgut microbiota, notably increasing beneficial Ligilactobacillus abundance. • Lose-dose Al and metformin improved metabolic disorders and demonstrates potential as a natural anti-diabetic agent.

Industrial Crops and ProductsVol. 240
First People’s Hospital of Jingmen (CN), Jingchu University of Technology (CN), Anhui Polytechnic University (CN)
Good health and well-being
Openalex Percentile: Top 90%
Metabolism, Diabetes, and Cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.